-
Sarepta Therapeutics (NASDAQ:SRPT) Rating Increased to Overweight at Cantor Fitzgerald
Source: Buzz FX / 07 Nov 2024 06:56:17 America/Chicago
Sarepta Therapeutics (NASDAQ:SRPT) Rating Increased to Overweight at Cantor Fitzgerald Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) was upgraded by investment
Read more...